O’FALLON, ILLINOIS. February 6, 2020 - Officials with MEDS are pleased to announce that Dr. John Vandover has been named as the new Chief Medical Officer.
“Dr. Vandover is a proven leader with a successful track record of enhancing clinical performance,” said Len Glover, DO, FACEP, President of MEDS. “As our CMO, Dr. Vandover will focus on excellence in clinical care, risk management, and clinical education of our providers.”Read More